These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22688539)

  • 1. Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008.
    Pan IJ; Yi HY
    Matern Child Health J; 2013 May; 17(4):667-76. PubMed ID: 22688539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.
    Faherty LJ; Kranz AM; Russell-Fritch J; Patrick SW; Cantor J; Stein BD
    JAMA Netw Open; 2019 Nov; 2(11):e1914078. PubMed ID: 31722022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada.
    Davies H; Gilbert R; Johnson K; Petersen I; Nazareth I; O'Donnell M; Guttmann A; Gonzalez-Izquierdo A
    Arch Dis Child Fetal Neonatal Ed; 2016 Jan; 101(1):F26-30. PubMed ID: 26290479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.
    Patrick SW; Schumacher RE; Benneyworth BD; Krans EE; McAllister JM; Davis MM
    JAMA; 2012 May; 307(18):1934-40. PubMed ID: 22546608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infant and maternal characteristics in neonatal abstinence syndrome--selected hospitals in Florida, 2010-2011.
    Lind JN; Petersen EE; Lederer PA; Phillips-Bell GS; Perrine CG; Li R; Hudak M; Correia JA; Creanga AA; Sappenfield WM; Curran J; Blackmore C; Watkins SM; Anjohrin S;
    MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(8):213-6. PubMed ID: 25742381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal drug use and its effect on neonates: a population-based study in Washington State.
    Creanga AA; Sabel JC; Ko JY; Wasserman CR; Shapiro-Mendoza CK; Taylor P; Barfield W; Cawthon L; Paulozzi LJ
    Obstet Gynecol; 2012 May; 119(5):924-33. PubMed ID: 22525903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the US prevalence of drug-using parturient women and drug-affected newborns, 1979 through 1990.
    Dicker M; Leighton EA
    Am J Public Health; 1994 Sep; 84(9):1433-8. PubMed ID: 8092367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview and epidemiology of substance abuse in pregnancy.
    Wendell AD
    Clin Obstet Gynecol; 2013 Mar; 56(1):91-6. PubMed ID: 23314721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between punitive policies and neonatal abstinence syndrome among Medicaid-insured infants in complex policy environments.
    Faherty LJ; Heins S; Kranz AM; Patrick SW; Stein BD
    Addiction; 2022 Jan; 117(1):162-171. PubMed ID: 34096671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: A review].
    Lamy S; Laqueille X; Thibaut F
    Encephale; 2015 Jun; 41 Suppl 1():S13-20. PubMed ID: 25439854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for out-of-home custody child care among families with alcohol and substance abuse problems.
    Sarkola T; Kahila H; Gissler M; Halmesmäki E
    Acta Paediatr; 2007 Nov; 96(11):1571-6. PubMed ID: 17850394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System.
    West KD; Ali MM; Blanco M; Natzke B; Nguyen L
    Matern Child Health J; 2023 Dec; 27(Suppl 1):14-22. PubMed ID: 37219692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The profile of substance-using pregnant mothers and their newborns at a regional rural hospital in New South Wales.
    Richardson R; Bolisetty S; Ingall C
    Aust N Z J Obstet Gynaecol; 2001 Nov; 41(4):415-9. PubMed ID: 11787916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal Abstinence Syndrome: Trend and Expenditure in Louisiana Medicaid, 2003-2013.
    Okoroh EM; Gee RE; Jiang B; McNeil MB; Hardy-Decuir BA; Zapata AL
    Matern Child Health J; 2017 Jul; 21(7):1479-1487. PubMed ID: 28168591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy-related substance use in the United States during 1996-1998.
    Ebrahim SH; Gfroerer J
    Obstet Gynecol; 2003 Feb; 101(2):374-9. PubMed ID: 12576263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse during pregnancy.
    Wheeler SF
    Prim Care; 1993 Mar; 20(1):191-207. PubMed ID: 8464941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
    Stabler ME; Long DL; Chertok IR; Giacobbi PR; Pilkerton C; Lander LR
    J Rural Health; 2017 Jan; 33(1):92-101. PubMed ID: 26879950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
    Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
    Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.